Moreover, some studies have demonstrated that glypican-3 (GPC3) was closely associated with tumor progression and acted as an oncogene in GC (Zhu et al., 2002; Ushiku et al., 2009), which was consistent with our findings. The gene discussed is GPC3; the disease is neoplasm.